A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: A trial coordinated by the Eastern Cooperative Oncology Group (E2100) Meeting Abstract
| Authors: | Miller, K. D.; Wang, M.; Gralow, J.; Dickler, M.; Cobleigh, M. A.; Perez, E. A.; Shenkier, T. N.; Davidson, N. E. |
| Abstract Title: | A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: A trial coordinated by the Eastern Cooperative Oncology Group (E2100) |
| Meeting Title: | 28th Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Breast Cancer Research and Treatment |
| Volume: | 94 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2005 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0167-6806 |
| Publisher: | Springer |
| Date Published: | 2005-12-01 |
| Start Page: | S6 |
| Language: | English |
| ACCESSION: | WOS:000233407100016 |
| PROVIDER: | wos |
| PUBMED: | 16374922 |
| DOI: | 10.1007/s10549-005-1234-6 |
| Notes: | --- - Meeting Abstract 3 - 28th Annual San Antonio Breast Cancer Symposium - DEC 08-11, 2005 - San Antonio, TX - "1" - "Source: Wos" |
